The classical case of the treatment of an adult patient with the salt-losing form of congenital adrenal cortical dysfunction
https://doi.org/10.14341/probl201157425-27
Abstract
References
1. Merke D.P., Cutler G.B. New ideas for medical treatment of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30: 121-135.
2. Merke D.P., Bornstein S.R., Avila N.A., Chrousos G.P. NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med 2002; 136: 320-334.
3. Speiser P.W., White P.C. Congenital adrenal hyperplasia. N Engl J Med 2003; 349: 776-788.
4. White P.C., Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 245-291.
5. Merke D.P., Bornstein S.R. Congenital adrenal hyperplasia. Lancet 2005; 365: 2125-2136.
6. Bachelot A., Chakthoura Z., Rouxel A. et al. Classical Forms of Congenital Adrenal Hyperplasia due to 21-Hydroxilase Deficiency in Adults. Horm Res 2008; 69: 203-211.
7. Bode H.H., Cowley D.M. et al. Home monitoring of 17-OHP levels in congenital adrenal hyperplasia. Journal of Pediatrics 1999; 134: 185-189.
8. Rosler A. The natural history of salt-wasting disorders of adrenal and renal origin. J Clin Endocrinol Metab 1984; 59: 689-700.
9. Merke D.P. Approach to the Adult with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. J Clin Endocrinol Metab 2008; 93: 3: 653-660.
10. Speiser P.W., Azziz R., Baskin L.S. et al. A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol 2010; 30.
11. Newell-Price J., Whiteman M., Rostami-Hodjegan A. et al. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf) 2008; 68: 130-135.
12. Charmandari E., Matthews D.R., Johnston A. et al. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab 2001; 86: 4679-4685.
13. Rosenfield R.L. Serum cortisol and 17-hydroxyprogesterone concentrations in children with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2002; 87: 2993.
14. Bachelot A., Chakhtoura Z., Samara-Boustani D. et al. Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency. Int J Pediatr Endocrinol 2010; 10: 326-275.
Review
For citations:
Sazonova A.I., Molashenko N.V., Iarovaia I.S., Kalinchenko N.I., Troshina E.A. The classical case of the treatment of an adult patient with the salt-losing form of congenital adrenal cortical dysfunction. Problems of Endocrinology. 2011;57(4):25-27. https://doi.org/10.14341/probl201157425-27
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
